| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |